PMC:6640909 / 42760-43728 JSONTXT

{"project":"TEST0","denotations":[{"id":"31100109-183-190-7395","span":{"begin":195,"end":198},"obj":"[\"23928368\"]"},{"id":"31100109-8-15-7396","span":{"begin":200,"end":203},"obj":"[\"19101239\"]"},{"id":"31100109-233-240-7397","span":{"begin":634,"end":637},"obj":"[\"28633205\"]"},{"id":"31100109-8-15-7398","span":{"begin":639,"end":642},"obj":"[\"17485581\"]"},{"id":"31100109-235-242-7399","span":{"begin":747,"end":750},"obj":"[\"21242487\"]"},{"id":"31100109-232-239-7400","span":{"begin":862,"end":865},"obj":"[\"23415314\"]"},{"id":"31100109-95-102-7401","span":{"begin":959,"end":962},"obj":"[\"25442985\"]"},{"id":"31100109-100-107-7402","span":{"begin":964,"end":967},"obj":"[\"16307998\"]"}],"text":"Recommendations Class Level References\nPathological evaluation of myocardial tissue obtained during apical coring to identify treatable aetiologies of heart failure is recommended. I C [410, 411]\nIn patients with LT-MCS with non-ischaemic cardiomyopathy, optimized medical heart failure therapy to promote myocardial recovery is recommended. I C [405]\nAdding a selective beta-2 adrenergic agonist to conventional HF therapy is not recommended. III B\nRoutine screening of patients with LT-MCS with non-ischaemic cardiomyopathy for myocardial recovery by echocardiography, including the ramp test, is recommended. I B [397, 412]\nBefore explantation, invasive haemodynamic examination of patients with LT-MCS is recommended. I B [398]\nCardiopulmonary exercise testing may be considered prior to the decision about LT-MCS explantation. IIb C [413]\nScreening for recurrence of heart failure after LT-MCS explantation is recommended. I C [414, 415]"}

{"project":"MyTest","denotations":[{"id":"31100109-23928368-28905455","span":{"begin":195,"end":198},"obj":"23928368"},{"id":"31100109-19101239-28905456","span":{"begin":200,"end":203},"obj":"19101239"},{"id":"31100109-28633205-28905457","span":{"begin":634,"end":637},"obj":"28633205"},{"id":"31100109-17485581-28905458","span":{"begin":639,"end":642},"obj":"17485581"},{"id":"31100109-21242487-28905459","span":{"begin":747,"end":750},"obj":"21242487"},{"id":"31100109-23415314-28905460","span":{"begin":862,"end":865},"obj":"23415314"},{"id":"31100109-25442985-28905461","span":{"begin":959,"end":962},"obj":"25442985"},{"id":"31100109-16307998-28905462","span":{"begin":964,"end":967},"obj":"16307998"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Recommendations Class Level References\nPathological evaluation of myocardial tissue obtained during apical coring to identify treatable aetiologies of heart failure is recommended. I C [410, 411]\nIn patients with LT-MCS with non-ischaemic cardiomyopathy, optimized medical heart failure therapy to promote myocardial recovery is recommended. I C [405]\nAdding a selective beta-2 adrenergic agonist to conventional HF therapy is not recommended. III B\nRoutine screening of patients with LT-MCS with non-ischaemic cardiomyopathy for myocardial recovery by echocardiography, including the ramp test, is recommended. I B [397, 412]\nBefore explantation, invasive haemodynamic examination of patients with LT-MCS is recommended. I B [398]\nCardiopulmonary exercise testing may be considered prior to the decision about LT-MCS explantation. IIb C [413]\nScreening for recurrence of heart failure after LT-MCS explantation is recommended. I C [414, 415]"}

{"project":"0_colil","denotations":[{"id":"31100109-23928368-7395","span":{"begin":195,"end":198},"obj":"23928368"},{"id":"31100109-19101239-7396","span":{"begin":200,"end":203},"obj":"19101239"},{"id":"31100109-28633205-7397","span":{"begin":634,"end":637},"obj":"28633205"},{"id":"31100109-17485581-7398","span":{"begin":639,"end":642},"obj":"17485581"},{"id":"31100109-21242487-7399","span":{"begin":747,"end":750},"obj":"21242487"},{"id":"31100109-23415314-7400","span":{"begin":862,"end":865},"obj":"23415314"},{"id":"31100109-25442985-7401","span":{"begin":959,"end":962},"obj":"25442985"},{"id":"31100109-16307998-7402","span":{"begin":964,"end":967},"obj":"16307998"}],"text":"Recommendations Class Level References\nPathological evaluation of myocardial tissue obtained during apical coring to identify treatable aetiologies of heart failure is recommended. I C [410, 411]\nIn patients with LT-MCS with non-ischaemic cardiomyopathy, optimized medical heart failure therapy to promote myocardial recovery is recommended. I C [405]\nAdding a selective beta-2 adrenergic agonist to conventional HF therapy is not recommended. III B\nRoutine screening of patients with LT-MCS with non-ischaemic cardiomyopathy for myocardial recovery by echocardiography, including the ramp test, is recommended. I B [397, 412]\nBefore explantation, invasive haemodynamic examination of patients with LT-MCS is recommended. I B [398]\nCardiopulmonary exercise testing may be considered prior to the decision about LT-MCS explantation. IIb C [413]\nScreening for recurrence of heart failure after LT-MCS explantation is recommended. I C [414, 415]"}

{"project":"2_test","denotations":[{"id":"31100109-23928368-28905455","span":{"begin":195,"end":198},"obj":"23928368"},{"id":"31100109-19101239-28905456","span":{"begin":200,"end":203},"obj":"19101239"},{"id":"31100109-28633205-28905457","span":{"begin":634,"end":637},"obj":"28633205"},{"id":"31100109-17485581-28905458","span":{"begin":639,"end":642},"obj":"17485581"},{"id":"31100109-21242487-28905459","span":{"begin":747,"end":750},"obj":"21242487"},{"id":"31100109-23415314-28905460","span":{"begin":862,"end":865},"obj":"23415314"},{"id":"31100109-25442985-28905461","span":{"begin":959,"end":962},"obj":"25442985"},{"id":"31100109-16307998-28905462","span":{"begin":964,"end":967},"obj":"16307998"}],"text":"Recommendations Class Level References\nPathological evaluation of myocardial tissue obtained during apical coring to identify treatable aetiologies of heart failure is recommended. I C [410, 411]\nIn patients with LT-MCS with non-ischaemic cardiomyopathy, optimized medical heart failure therapy to promote myocardial recovery is recommended. I C [405]\nAdding a selective beta-2 adrenergic agonist to conventional HF therapy is not recommended. III B\nRoutine screening of patients with LT-MCS with non-ischaemic cardiomyopathy for myocardial recovery by echocardiography, including the ramp test, is recommended. I B [397, 412]\nBefore explantation, invasive haemodynamic examination of patients with LT-MCS is recommended. I B [398]\nCardiopulmonary exercise testing may be considered prior to the decision about LT-MCS explantation. IIb C [413]\nScreening for recurrence of heart failure after LT-MCS explantation is recommended. I C [414, 415]"}